A New Journal in Pathology, Forging Frontiers in Disease Mechanism and Translational Innovation
en-GBde-DEes-ESfr-FR

A New Journal in Pathology, Forging Frontiers in Disease Mechanism and Translational Innovation

31/08/2026 HEP Journals

Despite remarkable advances in biomedical science, pathology—the cornerstone of disease diagnosis and therapeutic guidance—is facing an era of unprecedented transformation. Current epidemiological data underscore the urgency: in 2020, approximately 19.3 million new cancer cases and 10.0 million cancer-related deaths occurred globally, with China alone reporting 4.82 million new cases and 2.57 million deaths in 2022. Beyond oncology, pathological insights are equally vital for cardiovascular, respiratory, neurological, and metabolic diseases. However, the rapid evolution of life science technologies and the deepening integration of interdisciplinary approaches are reshaping the field, shifting it from traditional morphological observation toward multi-dimensional, high-throughput integrative analysis.
To address these challenges and fill a critical editorial gap at the intersection of basic research and clinical translation, a new international journal, Pathology Research, has been launched. Pathology Research is an international, peer-reviewed journal dedicated to publishing advances in experimen-tal, translational and clinical pathology. Our mission is to pioneer a holistic understanding of disease as a dynamic ecosystem, integrating the study of microen-vironment, microbiota, metabolite, nervous system, and pathophysiology. By fostering interdisciplinary collaboration among pathologists, clinicians, computer scientists, and biomedical researchers, the Journal covers a broad spectrum of pathology-related disciplines, including:
• Surgical and molecular pathology
• Artificial intelligence in pathology
• Spatial multi-omics and molecular genetics
Pathology Research presents original research articles, reviews, guidelines, case reports, consensus statements, perspectives, and commentaries.
Pathology Research is guided by a distinguished inter-national editorial board of leading experts in pathology, and related interdisciplinary fields. This board ensures comprehensive, rigorous peer review of all submissions while upholding the highest standards of academic integrity. Our goal is to establish Pathology Research as a leading platform in the field of pathology. We warmly invite you to contribute your valuable work, join us to drive theoretical innovation and clinical translation in pathological research. Together, we can improve disease diagnosis, optimize treatment strategies, and reduce the global burden of diseases.
doi:10.2738/PR.2026.0001
31/08/2026 HEP Journals
Regions: Asia, China
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement